FDA committee questions Fluosol efficacy; US approval not imminent
Marwick, C.
JAMA 250(19): 2585-2586
1983
ISSN/ISBN: 0098-7484 PMID: 6632147 Document Number: 213851
Document emailed within 1 workday
Related Documents
McCarthy, M. 2015: Report questions FDA approval of controversial anticoagulant Bmj 351: H5557Fredd, S.B. 1990: The OTC drug approval process. The ACG Committee on FDA-Related Matters. American College of Gastroenterology American Journal of Gastroenterology 85(1): 12-14
Cohen, M.H.; Johnson, J.R.; Pazdur, R. 2005: U.S. Food and Drug Administration Drug Approval Summary: conversion of imatinib mesylate (STI571; Gleevec) tablets from accelerated approval to full approval Clinical Cancer Research: An Official Journal of the American Association for Cancer Research 11(1): 12-19
Astrup, K.G.; Riis, P. 1995: Drug approval. Orientation from the drug department of the National Board of Health and Welfare and the scientific-ethical committee system Ugeskrift for Laeger 157(46): 6442-6443
Katz, S. 1990: Biliary lithotripsy: more questions than answers. The ACG Committee on FDA-Related Matters American Journal of Gastroenterology 85(5): 497-509
Norsworthy, G.D. 1999: Questions efficacy of vaccinating cats at 3-year intervals American Journal of Veterinary Research 60(8): 918-919
Cherubin, C.E.; Eng, R.H.; Smith, S.M.; Goldstein, E.J. 1986: Cephalosporin therapy for salmonellosis. Questions of efficacy and cross resistance with ampicillin Archives of Internal Medicine 146(11): 2149-2152
Elferink, A.J.; Toivonen, M.; van Bronswijk, H. 1999: Safety and efficacy of vigabatrin and carbamazepine. CPMP. The Committee for Proprietary Medicinal Products Lancet 354(9187): 1387-1388
International Council For The Exploration, O.The Sea 2006: Report of the ICES Advisory Committee on Fishery Management, Advisory Committee on the Marine Environment and Advisory Committee on Ecosystems, 2006. Book 10: North Atlantic salmon stocks ICES Advice Book 10: i-iii, 1-58
International Council For The Exploration, O.The Sea 2006: Report of the ICES Advisory Committee on Fishery Management, Advisory Committee on the Marine Environment and Advisory Committee on Ecosystems, 2006. Book 10: North Atlantic salmon stocks ICES Advice Book 10: i-iii, 1-58
Lustig, R.A.; McIntosh, N.L. 1986: Fluosol-DA in radiation therapy Progress in Clinical and Biological Research 211: 29-38
Gould, S.A.; Rosen, A.L.; Sehgal, L.R.; Sehgal, H.L.; Moss, G.S. 1983: Clinical experience with Fluosol-DA Progress in Clinical and Biological Research 122: 331-342
Hammarstrom, M.; Mullins, R.; Sgoutas, D. 1983: Effect of Fluosol-DA on radioimmunoassay results Clinical Chemistry 29(7): 1418-1421
Rousou, J.A.; Engelman, R.M.; Anisimowicz, L.; Dobbs, W.A. 1985: A comparison of blood and Fluosol-DA for cardiopulmonary bypass Journal of Cardiovascular Surgery 26(5): 447-453
Mitsuno, T.; Tabuchi, Y.; Ohyanagi, H.; Sugiyama, T. 1983: Further studies on intake and retention of PFC substance of Fluosol-DA in RES in humans Progress in Clinical and Biological Research 122: 257-263
Teicher, B.A.; Holden, S.A. 1987: Survey of the effect of adding Fluosol-DA 20%/O2 to treatment with various chemotherapeutic agents Cancer Treatment Reports 71(2): 173-177
Rousou, J.A.; Engelman, R.M.; Breyer, R.H.; Allred, C.; Forouhar, F. 1985: Short term survival following perfusion with fluosol-DA for cardiopulmonary bypass International Journal of Artificial Organs 8(5): 281-286
Hirlinger, W.K.; Grünert, A.; Herrmann, M.; Petutschnigk, D.; Langer, K. 1982: Effects of a partial exchange transfusion with Fluosol DA 20% on healthy pigs Der Anaesthesist 31(12): 660-666
Tremper, K.K.; Perloff, W.; Levine, E.M.; Shippy, C. 1983: More on the performance of the IL282 CO-oximeter in the presence of perfluorochemical emulsion, Fluosol-DA Clinical Chemistry 29(1): 209-210
Kelly, L.S. 1989: When hanging is imminent. Nursing Outlook 37(5): 213